Skip to content
Popular Searches
  • # Cancer
  • # FDA
  • # Alzheimer's
  • # Hoffmann-La Roche
  • # DNA
  • # Diabetes
  • linkedin
  • facebook
  • instagram
  • twitter
  • youtube
Home BiotechReality – Covering Industry, Business, and Academia

Explore the frontiers of Biotechnology, Pharma/Biopharma industry and Science with BiotechReality. We publish news, reports, views and articles.

  • Healthcare & Pharmaceuticals
    • Business
    • Pharmacology
  • Clinical Trials
    • Regulatory Approval
  • Biotechnology
    • Molecular Biology
    • Genomics
    • Immunology
    • Microbiology
      • Virology
    • Diagnostic Tests
  • Science
    • Microbiology
    • Research
    • General Biology
  • Technology
    • Artificial Intelligence
  • News
    • Research
Trending

Trending

Based on Results From the Phase 3 BRUIN CLL-321 trial, Lilly’s Jaypirca (pirtobrutinib) recommended by CHMP for approval in the European Union

1 March 2025

New studies investigate potential treatments for cancer and other illnesses

6 December 2024

FDA grants approval for the blood cancer therapy of Pfizer

19 August 2023

Researchers map fifty thousand of the human genome’s cryptic “knots” of DNA

1 September 2024

Nipah Virus (NiV) – Details

12 September 2023

Roche’s VENTANA MET (SP44) RxDx Assay Receives FDA Approval as First Companion Diagnostic for MET-Positive NSCLC

15 May 2025

Research promises a universal flu vaccine

22 July 2024

Advanced heart regenerative therapy using stem cell-derived heart muscle cells

1 May 2024

A Rare Side Effect for Cancer Immunotherapy Detected

24 February 2025

Eli Lilly Reported a Very Strong Start to 2025, Characterized by Significant Revenue Growth

1 May 2025

AstraZeneca Released KALOS and LOGOS Phase III Clinical Trials Result Shows Positive High-level Results of Breztri for Treating Asthma

2 May 2025

Researchers created artificial cells that mimic the original cells

27 April 2024

Anti-obesity drugs

AbbVie Enters Into the Obesity Drug Market With a License Agreement
Anti-obesity Drugs Business News

AbbVie Enters Into the Obesity Drug Market With a License Agreement

Editor's Desk 5 March 2025

GUB014295 is a calcitonin and amylin receptor-specific agonist that may be a long-acting amylin analog.

Areas Covered

  • Anti-obesity Drugs
  • Artificial Intelligence
  • Astrobiology
  • Biochemistry
  • Bioengineering
  • Bioinformatics
  • Biostatistics
  • Biotechnology
  • Blog
  • Business
  • Cancer
  • Cell Biology
  • Clinical Investigation
  • Clinical Trials
  • Collection
  • Deep Learning
  • Diabetes
  • Diagnostic Tests
  • Disease Biology
  • Diseases
  • Drug Discovery
  • Drugs
  • Engineering
  • Epidemiology
  • Gene Therapy
  • General Biology
  • Genetics
  • Genomics
  • Healthcare & Pharmaceuticals
  • Immunology
  • Immunotherapy
  • Instrumentation
  • Laboratory Info
  • Life Sciences
  • Machine Learning
  • Medical Devices
  • Mental Health
  • Microbiology
  • Microscopy
  • Molecular Biology
  • Nanotechnology
  • Neuroscience
  • News
  • Oncology
  • Pharmacology
  • Regenerative Medicine
  • Regulatory
  • Regulatory Approval
  • Research
  • Science
  • Science Communication
  • Supply Chain
  • Technology
  • Therapies
  • Toxicology
  • Vaccines
  • Virology
  • Weight-loss Drugs
Market Analysis
Publish on BiotechReality

  • ICON Hiring a Clinical Data Programming Lead in Chennai, India
  • PhD Position in Food Biotechnology – University of Reading, United Kingdom
  • Novo Nordisk Engineering (NNE) is Hiring a Manufacturing Execution System (MES) Analyst in Bengaluru, India
  • Sartorius is Hiring a Process Technology Engineer in Bengaluru, India – May, 2025
  • Cytiva Hiring a Logistics Specialist in Singapore – May 2025
SciRealityPress BiotechReality

A SciRealityPress Associate

Contents in the website is licensed under CC BY-NC 4.0

Disclaimer: The content on this website is not meant to provide medical or any other professional advice. Understand and use the information, double check if necessary. All trademarked names mentioned in the contents belongs to their respective owners. Stock exchange data providing by Stockdio

SciRealityPress © 2025
  • About
  • Contact
  • Privacy Policy
  • Terms & Conditions
  • Disclaimer
  • Platform Status
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.ContinuePrivacy policy